First, the Biotech Forum:
• A one-on-one interview with Tony Coles, president and CEO of Onyx Pharmaceuticals;
• A panel discussion with Craig Muir of Third Rock Ventures, Glenn Oclassen of Transcept Pharmaceuticals, Lissa Goldenstein of Auxogyn and Gideon Bollag of Plexxikon;
• Three companies -- Avalanche Biotechnologies, Neuraltus Pharmaceuticals and Organ-i -- will talk about the knotty scientific problems they're trying to solve.
The event is 7:30-10 a.m. Thursday, June 14, at the Hilton San Francisco Union Square at 333 O'Farrell St.